PT966683E - Ensaios agentes terapia e diagnostico relativos a modulacao de actividade de reparacao de adn celular - Google Patents

Ensaios agentes terapia e diagnostico relativos a modulacao de actividade de reparacao de adn celular

Info

Publication number
PT966683E
PT966683E PT98900589T PT98900589T PT966683E PT 966683 E PT966683 E PT 966683E PT 98900589 T PT98900589 T PT 98900589T PT 98900589 T PT98900589 T PT 98900589T PT 966683 E PT966683 E PT 966683E
Authority
PT
Portugal
Prior art keywords
activity
dna
cellular dna
reparation
modulation
Prior art date
Application number
PT98900589T
Other languages
English (en)
Inventor
Stephen Philip Jackson
Susan Elizabeth Critchlow
Original Assignee
Kudos Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700574.8A external-priority patent/GB9700574D0/en
Priority claimed from GBGB9713131.2A external-priority patent/GB9713131D0/en
Application filed by Kudos Pharm Ltd filed Critical Kudos Pharm Ltd
Publication of PT966683E publication Critical patent/PT966683E/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/9015Ligases (6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98900589T 1997-01-13 1998-01-13 Ensaios agentes terapia e diagnostico relativos a modulacao de actividade de reparacao de adn celular PT966683E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700574.8A GB9700574D0 (en) 1997-01-13 1997-01-13 Methods and means relating to retrotransposon and retroviral integration
GBGB9713131.2A GB9713131D0 (en) 1997-06-20 1997-06-20 Assays,therapeutic and diagnostic methods and means

Publications (1)

Publication Number Publication Date
PT966683E true PT966683E (pt) 2003-08-29

Family

ID=26310785

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98900589T PT966683E (pt) 1997-01-13 1998-01-13 Ensaios agentes terapia e diagnostico relativos a modulacao de actividade de reparacao de adn celular

Country Status (12)

Country Link
US (1) US6753158B1 (pt)
EP (1) EP0966683B1 (pt)
JP (1) JP2001508868A (pt)
AT (1) ATE237136T1 (pt)
AU (1) AU724108B2 (pt)
CA (1) CA2277481A1 (pt)
DE (1) DE69813194T2 (pt)
DK (1) DK0966683T3 (pt)
ES (1) ES2197453T3 (pt)
GB (1) GB2322193B (pt)
PT (1) PT966683E (pt)
WO (1) WO1998030902A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569681B1 (en) 2000-03-14 2003-05-27 Transkaryotic Therapies, Inc. Methods of improving homologous recombination
DE10161829B4 (de) * 2001-12-15 2006-02-16 Peter Lahnert Neue Methode zur Bestimmung der Telomerlänge und ihre Verwendung zur Abschätzung des Lebensalters
PL2295056T3 (pl) * 2004-03-15 2016-07-29 Sunesis Pharmaceuticals Inc Zastosowanie SNS-595 do leczenia białaczki
US8580814B2 (en) 2006-04-03 2013-11-12 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
US8124773B2 (en) 2006-06-12 2012-02-28 Sunesis Pharmaceuticals, Inc. 1,8-naphthyridine compounds for the treatment of cancer
US20130273656A1 (en) * 2010-10-08 2013-10-17 Regents Of The University Of Minnesota Method to increase gene targeting frequency
EP2983665A1 (en) * 2013-03-15 2016-02-17 The Regents of The University of California Therapeutic agents and methods for the treatment of dna repair deficiency disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07505057A (ja) * 1993-01-21 1995-06-08 ザ サルク インスティテュート フォー バイオロジカル スタディーズ プロテインキナーゼ
WO1995010288A1 (en) * 1993-10-12 1995-04-20 Baylor College Of Medicine Hepatitis b virus interacts with cellular dna repair processes
AU2201695A (en) * 1995-03-31 1996-10-16 Human Genome Sciences, Inc. Human dna ligase iii

Also Published As

Publication number Publication date
ATE237136T1 (de) 2003-04-15
DE69813194T2 (de) 2004-02-05
ES2197453T3 (es) 2004-01-01
GB2322193B (en) 1999-09-29
WO1998030902A1 (en) 1998-07-16
GB2322193A (en) 1998-08-19
EP0966683A1 (en) 1999-12-29
US6753158B1 (en) 2004-06-22
DE69813194D1 (de) 2003-05-15
AU724108B2 (en) 2000-09-14
DK0966683T3 (da) 2003-08-04
EP0966683B1 (en) 2003-04-09
GB9800663D0 (en) 1998-03-11
CA2277481A1 (en) 1998-07-16
JP2001508868A (ja) 2001-07-03
AU5568198A (en) 1998-08-03

Similar Documents

Publication Publication Date Title
DK1131471T3 (da) Et system til cellebaseret screening
IL147793A0 (en) Optical system analysis of cells
ES2080044T3 (es) Moleculas de adhesion intercelular y sus ligandos de fijacion.
WO2000050872A3 (en) A system for cell-based screening
ATE397251T1 (de) Verfahren für das entwerfen von kleinen erythropoietin mimetika
ES2053532T3 (es) Metodos de inmunoensayo.
MX9203469A (es) Molecula de adherencia intercelular-2 y sus ligandos de fijacion.
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DE69838090D1 (de) Mehrgefässplatten mit kleiner störstrahlung für fluoreszenzmessungen von biologischen und biochemischen proben
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
DK412589D0 (da) Alfa-underenheden af lfa-1-leukocytadhaesionsreceptoren
WO2001011341A3 (en) A system for cell-based screening
PT966683E (pt) Ensaios agentes terapia e diagnostico relativos a modulacao de actividade de reparacao de adn celular
ATE246245T1 (de) Interzellulare adhäsions-moleküle und deren bindungsliganden
DE69731964D1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
DE3674933D1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
FI972215A (fi) Uusia polypeptidejä
FI901468A0 (fi) Testipakkaus entsyymien määritykseen ja määritysmenetelmä
MX9606065A (es) Proteina fijadora de atp y acidos nucleicos con supuestas propiedades de helicasa y atpasa.
ATE386142T1 (de) Fluoreszenz-basierte assays von dns-primasen